Brelovitug 300 mg
BJT-778-301
Phase 3 small_molecule active
Quick answer
Brelovitug 300 mg for Chronic Hepatitis D Infection is a Phase 3 program (small_molecule) at Mirum Pharmaceuticals with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Mirum Pharmaceuticals
- Indication
- Chronic Hepatitis D Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active